MeSH term
Frequency | Condition_Probility | Humans | 67 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Base Sequence | 13 | 0.0 |
Child, Preschool | 2 | 0.0 |
Electrocardiography | 15 | 4.0 |
English Abstract | 4 | 0.0 |
Male | 30 | 0.0 |
Molecular Sequence Data | 15 | 0.0 |
Pedigree | 21 | 0.0 |
Phenotype | 16 | 0.0 |
Prognosis | 5 | 0.0 |
Sodium Channels/*genetics | 4 | 4.0 |
Animals | 40 | 0.0 |
Mutation | 17 | 0.0 |
Potassium Channels/genetics | 4 | 8.0 |
*Potassium Channels, Voltage-Gated | 52 | 19.0 |
Research Support, Non-U.S. Gov't | 61 | 0.0 |
Cell Line | 5 | 0.0 |
Hamsters | 11 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
In Vitro | 4 | 0.0 |
Myocardium/cytology/*metabolism | 2 | 4.0 |
Patch-Clamp Techniques | 11 | 2.0 |
Potassium/metabolism | 5 | 4.0 |
Potassium Channel Blockers | 4 | 15.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
DNA Mutational Analysis | 14 | 0.0 |
Female | 32 | 0.0 |
Genotype | 7 | 0.0 |
*Heterozygote | 2 | 0.0 |
Long QT Syndrome/genetics | 5 | 35.0 |
*Mutation | 10 | 0.0 |
Mutation, Missense | 7 | 0.0 |
Polymorphism, Single-Stranded Conformational | 15 | 0.0 |
Potassium Channels/*genetics | 19 | 14.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Rats | 4 | 0.0 |
CHO Cells | 7 | 0.0 |
Gene Expression | 8 | 0.0 |
Gene Therapy | 2 | 0.0 |
Guinea Pigs | 2 | 0.0 |
Transfection | 10 | 0.0 |
Electric Conductivity | 10 | 5.0 |
Hydrogen-Ion Concentration | 3 | 0.0 |
Oocytes | 5 | 4.0 |
Potassium Channels/genetics/*physiology | 3 | 27.0 |
Xenopus laevis | 12 | 2.0 |
COS Cells | 4 | 0.0 |
China | 4 | 0.0 |
Ion Transport | 2 | 2.0 |
Middle Aged | 8 | 0.0 |
Potassium Channels, Voltage-Gated/*genetics | 2 | 25.0 |
Adult | 10 | 0.0 |
Long QT Syndrome/*genetics | 11 | 28.0 |
Aged | 6 | 0.0 |
Comparative Study | 3 | 0.0 |
Family Health | 5 | 0.0 |
Gene Expression Regulation/genetics | 2 | 1.0 |
Structure-Activity Relationship | 3 | 0.0 |
Colon/chemistry | 2 | 10.0 |
Electrophysiology | 9 | 2.0 |
Ion Channel Gating | 2 | 2.0 |
Mice | 11 | 0.0 |
Rabbits | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
*Cation Transport Proteins | 10 | 4.0 |
*DNA-Binding Proteins | 9 | 0.0 |
Potassium Channels/genetics/*metabolism | 3 | 11.0 |
*Trans-Activators | 8 | 1.0 |
Heterozygote | 2 | 0.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
Oocytes/metabolism | 4 | 2.0 |
Potassium Channels/*genetics/metabolism | 2 | 7.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Potassium Channels/*genetics/*metabolism | 2 | 18.0 |
DNA Primers | 3 | 0.0 |
Microsatellite Repeats/genetics | 2 | 0.0 |
Action Potentials | 4 | 6.0 |
Death, Sudden, Cardiac | 2 | 33.0 |
Mutation/*genetics | 3 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Adolescent | 7 | 0.0 |
Child | 6 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Long QT Syndrome/*genetics/physiopathology | 2 | 25.0 |
In Situ Hybridization | 3 | 0.0 |
Kinetics | 3 | 0.0 |
Protein Binding | 2 | 0.0 |
Xenopus | 4 | 0.0 |
Alleles | 2 | 0.0 |
*Genetic Screening | 3 | 1.0 |
Long QT Syndrome/ethnology/*genetics | 2 | 100.0 |
Cloning, Molecular | 3 | 0.0 |
Genes, Recessive | 2 | 0.0 |
Microinjections | 2 | 0.0 |
Potassium Channels/chemistry/*genetics | 2 | 20.0 |
Heart/physiology | 2 | 5.0 |
Oocytes/physiology | 3 | 2.0 |
Potassium/pharmacology | 2 | 3.0 |
Cricetulus | 2 | 0.0 |
Membrane Potentials/physiology | 2 | 2.0 |
Chromosome Mapping | 3 | 0.0 |
Cation Transport Proteins/genetics | 2 | 12.0 |
Long QT Syndrome/diagnosis/*genetics | 4 | 100.0 |
Sodium Channels/genetics | 3 | 12.0 |
Models, Genetic | 2 | 0.0 |
Genetic Screening/methods | 2 | 1.0 |
Exons | 2 | 0.0 |
Point Mutation/*genetics | 2 | 0.0 |
Algorithms | 3 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Genetic Predisposition to Disease/genetics | 2 | 0.0 |
Mutation, Missense/genetics | 2 | 1.0 |
Cells, Cultured | 2 | 0.0 |
Calcium Channel Blockers/*pharmacology | 2 | 5.0 |
Chromatography, High Pressure Liquid/*methods | 2 | 1.0 |
Nucleic Acid Denaturation | 2 | 2.0 |
Electric Stimulation | 3 | 1.0 |
Ion Channel Gating/drug effects | 2 | 10.0 |
Time Factors | 2 | 0.0 |
Brachial Plexus/physiology | 2 | 100.0 |
*Electromagnetic Fields | 2 | 6.0 |
Electromyography | 2 | 1.0 |
Evoked Potentials, Motor/physiology | 2 | 18.0 |
Isometric Contraction/physiology | 2 | 16.0 |
Motor Neurons/physiology | 2 | 4.0 |
Muscle Contraction/physiology | 2 | 4.0 |
Muscle Fatigue/*physiology | 2 | 15.0 |
Muscle, Skeletal/innervation/*physiology | 2 | 28.0 |
Nerve Fibers/physiology | 2 | 13.0 |
